Bioequivalence Of Dabigatran Etexilate Mesylate Capsules From Two Different Manufacturers In Healthy Chinese Subjects

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Bioequivalence Of Dabigatran Etexilate Mesylate Capsules From Two Different Manufacturers In Healthy Chinese Subjects trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 1

NCT06876623

Bioequivalence Study of Two Dabigatran Etexilate Mesylate Capsules in Healthy Subjects

In recent years, novel oral anticoagulants (NOACs) such as Factor Xa inhibitors and direct thrombin inhibitors (e.g., dabigatran etexilate) have emerged. These…

China88 participantsStarted 2019-12-10

Treatment: dabigatran etexilate mesylate capsules 150mg